Ebook: Benefit-Risk Assessment in Pharmaceutical Research and Development
- Series: Chapman & Hall/CRC Biostatistics Series.
- Year: 2013
- Publisher: Taylor and Francis
- City: Hoboken
- Language: English
- pdf
Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment across the pharmaceutical R&D Read more...
Front Cover; Contents; Editors; Contributors; Prologue; Chapter 1: Pharmaceutical Benefit-Risk Assessment in Early Development; Chapter 2: Key Questions, Issues, and Challenges in Benefit-Risk Assessment in Full Clinical Development; Chapter 3: The Clinical Aspects of Benefit and Risk; Chapter 4: Quantifying Patient Preferences to Inform Benefit-Risk Evaluations; Chapter 5: Benefit-Risk Modeling of Medicinal Products: Methods and Applications; Chapter 6: Benefit-Risk Communication: Learning from Our Past and Creating Our Future Chapter 7: Policy Considerations and Strategic Issues Regarding Benefit-RiskChapter 8: Systematic Approaches to Benefit-Risk Assessment; Chapter 9: Considerations and Strategies for Benefit-Risk Assessment in the Real-World Setting; Chapter 10: Benefit-Risk Assessment and the Payer Perspective; Epilogue; Glossary; Back Cover